AbbVie buying Irish drug firm Allergan in $63 billion deal

AbbVie Inc. said it's buying Dublin, Ireland-based drug firm Allergan in a $63 billion deal. AbbVie (NYSE: ABBV), based in North Chicago, Illinois, said it's paying 0.8660 of its shares and $120.30 in cash for each Allergan (NYSE: AGN) share, for a total consideration of $188.24 per Allergan share. AbbVie said the combined companies' headquarters will remain in North Chicago. "This is a transformational transaction for both companies and achieves unique and complementary strategic objectives.…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news